Pharmaceutical Industry News

News

Buy Johnson & Johnson While It's Cheap - Seeking Alpha
seekingalpha.com | 11 hours 43 minutes ago
< strong > By < a href='http://www.fastgraphs.com/' > F.A.S.T. Graphs < /a > : < /strong > < p > < strong > Johnson & amp; Johnson ( < a href='http://seekingalpha.com/symbol/jnj' title='Johnson & Johnson' > JNJ < /a > ) < /strong > is one of the premier blue-chip companies in the world. It is one

FDA Approves Merck Co Inc Drug for Glaucoma
www.biospace.com | 16 hours 3 minutes ago
WHITEHOUSE STATION, N.J., Feb 13, 2012 -- Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug

Process Analytical Technology | Watson Commits to PAT and QbD for Generic Drug Development |
www.pharmamanufacturing.com | Feb 14, 2012
Watson Pharmaceuticals, Inc. announced plans to establish a Global R&D Technology Center in North Brunswick, New Jersey. The Company has signed a lease for a 32,000-square-foot facility at the New Jersey Economic Development Authority's Technology Centre of New Jersey, a 50-acre complex consisting

Merck News Item
www.merck.com | Feb 14, 2012
Merck & Co., Inc. home investors newsroom licensing careers contact us United States Canada MSD Worldwide About Us Our Values Be well Leadership How We Operate Views and Positions Our History Featured Stories Corporate Responsibility Research Pipeline Discovery & Development Products Vaccines

Viralyti | Viralytics appoints non-executive director | PharmaAsia
www.pharmaasia.com | Feb 14, 2012
Dr Leonard Post has been appointed as a non-executive director of Viralytics.

Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing | PRLog
www.prlog.org | Feb 13, 2012
Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing. Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - PR11797820

A STEPP too far for FLEX? – Authors' reply : The Lancet Oncology
www.thelancet.com | Feb 13, 2012
A STEPP too far for FLEX? – Authors' reply. By - Robert Pirker, Stephan Störkel, Anja von Heydebreck, Ilhan Celik, Kenneth J O'Byrne

Mylan CEO Heather Bresch Testifies Before Congress in Support of Generic Drug User Fee Program and
www.sys-con.com | Feb 9, 2012
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.

FitchResearch
www.fitchratings.com | Feb 6, 2012
Fitch Ratings About Us Contact Us Press Room Events Help Search Sign in Autologin Printer-Friendly Page Click Here for Printer-Friendly Version Fitch Assigns Initial IDR of 'BBB-' to Ache Laboratorios Ratings Endorsement Policy 06 Feb 2012 1:19 PM (EST) Fitch Ratings-Rio de Janeiro/Chicago-06

Pharma seeks to ease pain of euro crisis - FT.com
www.ft.com | Feb 5, 2012
With Greece and Spain struggling to repay billions of euros in outstanding debts to the healthcare sector as the eurozone crisis festers, Merck of Germany is stepping up action to ease the pain. “We have introduced cash on delivery and are looking